We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$75M |
| 2 |
Biogen
BIIB
|
+$70.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$60.1M |
| 4 |
Merck
MRK
|
+$54.6M |
| 5 |
Gilead Sciences
GILD
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.1M |
| 2 |
IRBT
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.4M |
| 4 |
Colgate-Palmolive
CL
|
+$14.8M |
| 5 |
Philip Morris
PM
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.26% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
626
DELISTED
Intersect ENT, Inc
XENT
| $863K | 0.01% |
30,000
| – | – |
|
627
Thomson Reuters
TRI
$39.4B
| $856K | 0.01% |
16,178
-9,846
| -38% | -$493K |
|
|
CIT
628
DELISTED
CIT Group Inc.
CIT
| $853K | 0.01% |
16,520
| – | – |
|
629
Newell Brands
NWL
$2.16B
| $850K | 0.01% |
41,870
+3,293
| +9% | +$77.3K |
|
630
Akamai
AKAM
$16.8B
| $844K | 0.01% |
11,532
-4,764
| -29% | -$358K |
|
631
Ingredion
INGR
$6.38B
| $840K | 0.01% |
8,000
+3,825
| +92% | +$391K |
|
|
KL
632
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $837K | 0.01% |
44,197
| – | – |
|
|
CHL
633
DELISTED
China Mobile Limited
CHL
| $833K | 0.01% |
17,030
| – | – |
|
634
Amplify Cybersecurity ETF
HACK
$2.63B
| $827K | 0.01% |
20,600
+4,300
| +26% | +$167K |
|
635
PVH
PVH
$3.71B
| $822K | 0.01% |
5,691
-33,829
| -86% | -$5M |
|
|
BNFT
636
DELISTED
Benefitfocus, Inc.
BNFT
| $809K | 0.01% |
+20,000
| New | +$769K |
|
637
Norwegian Cruise Line
NCLH
$8.89B
| $806K | 0.01% |
14,029
-340
| -2% | -$17.6K |
|
|
OMED
638
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $806K | 0.01% |
380,000
| – | – |
|
|
XEC
639
DELISTED
CIMAREX ENERGY CO
XEC
| $798K | 0.01% |
8,581
+1,154
| +16% | +$106K |
|
|
QVCGA
640
DELISTED
QVC Group Inc Series A
QVCGA
| $783K | 0.01% |
727
-55
| -7% | -$57.8K |
|
641
British American Tobacco
BTI
$132B
| $763K | 0.01% |
16,363
-2,852
| -15% | -$145K |
|
|
VER
642
DELISTED
VEREIT, Inc.
VER
| $753K | 0.01% |
20,749
| – | – |
|
|
PBCT
643
DELISTED
People's United Financial Inc
PBCT
| $750K | 0.01% |
43,806
-79,307
| -64% | -$1.45M |
|
644
Chipotle Mexican Grill
CMG
$40.8B
| $746K | 0.01% |
82,050
-50
| -0.1% | -$476 |
|
645
Molina Healthcare
MOH
$10.3B
| $744K | 0.01% |
5,000
-2,000
| -29% | -$255K |
|
646
Howmet Aerospace
HWM
$116B
| $742K | 0.01% |
43,960
| – | – |
|
647
Albemarle
ALB
$13.5B
| $740K | 0.01% |
7,419
-8,976
| -55% | -$869K |
|
648
Western Union
WU
$2.57B
| $740K | 0.01% |
38,844
| – | – |
|
649
CAE Inc. Common Shares
CAE
$8.1B
| $734K | 0.01% |
36,187
+199
| +0.6% | +$4.07K |
|
|
CTRA
650
DELISTED
Coterra Energy
CTRA
| $725K | 0.01% |
32,190
+3,324
| +12% | +$77.6K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2018 Portfolio in Review
As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.
- Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
- Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
- Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
- Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
- Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
- Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.
Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.